Background clinical samples

The analysis of clinical samples is often complicated by the complexity of the sample matrix, which may contribute a significant background absorption at the desired wavelength. The determination of serum barbiturates provides one example of how this problem is overcome. The barbiturates are extracted from a sample of serum with CHCI3, and extracted from the CHCI3 into 0.45 M NaOH (pH 13). The absorbance of the aqueous extract is measured at 260 nm and includes contributions from the barbiturates as well as other components extracted from the serum sample. The pH of the sample is then lowered to approximately 10 by adding NH4CI, and the absorbance remeasured. Since the barbiturates do not absorb at this pH, the absorbance at pH 10 is used to correct the absorbance at pH 13 thus... 

The 3-OH FAs have had great utility in the determination of LPS levels in indoor air. However, in tissues and body fluids it has been determined that 3-OH FAs are naturally present at low levels as products of mammalian metabolism (mitochondrial fatty acid p oxidation). Due to this background GC-MS/MS for 3-OH FAs is not recommended as a general marker to determine trace LPS levels in clinical samples [14]. However, in certain situations the assessment of 3-OH FAs has been successfully used, for example, in the diagnosis of chronic peridontitis [15]. There is great potential for the utility of 3-OH FAs as markers for LPS contamination in pharmaceutical products, where often the background matrix would be anticipated to be much less complex. 

The fidelity and sensitivity of NASBA have both been demonstrated (2). NASBA achieves amplification in the order of 10 -fold in approx 90 min, with an error frequency of <0.3%. And in reconstructed clinical samples, e.g., fewer than 10 KV molecules are detectable in a drop of human blood (3). The use of nested primers in particularly complex samples augments the specific amplification of target sequences relative to the background. 

A significant effort was necessary to obtain accurate results for selenium in blood, plasma, and erythrocytes [27]. Iron causes a spectral interference at the selenium line at 196 nm if a continuum source background corrector is used, causing erroneous results particularly in blood and erythrocytes. Zeeman effect background correction is therefore mandatory for the determination of selenium in clinical samples. In addition, some of the previously recommended chemical modifiers were found to stabilize the different selenium species differently, so that some of them may be lost in the pyrolysis stage. A mixture of palladium and magnesium nitrates was found to solve the problem and prevent any preatomization losses [28]. 

The best conclusion that can be drawn from these data is perhaps that treatment with naltrexone may offer promise for some, but certainly not all, patients with self-injury. Treatment effects may depend on background opioid levels, dosage, and treatment regimen. Noninvasive measures that predict individual treatment response have not been established. Self-injury is a heterogeneous phenomenon from a clinical and biological perspective (Buitelaar, 1993 Willemsen-Swinkels et ah, 1998). Further studies are required in this area, and and should include carefully clinically documented cases, large samples, and controlled designs. At this time, the use of naltrexone for the treatment of self-injury is to be considered experimental. 

Mass cytometry uses stable isotopes as lanthanide series because of the huge number of elements of this family and their similar chemical structure, allowing their incorporation into the same tag (45,46). They also exhibit very low background due to their intrinsic low natural abundance (45-47). These rare earth elements are relatively biocompatible and easily conjugated to biomolecules by broad availability and simple protocols. Finally, they proffer high sensitivity for traces of molecules in biological samples, being attractive markers for their use in the clinical routine (47). 

---